Diadia
Our TechnologyResearchResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

detoxification · Mechanism Report

Does elevated mycophenolic acid and zearalenone with other mycotoxins normal suggest selective exposure?

Elevated urinary mycophenolic acid and zearalenone with other measured mycotoxins normal is compatible with a selective detectable-exposure pattern in that sample, but it does not establish that conclusion.

PlausibleSeptember 23, 202610 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Mycophenolic acid is a fungal secondary metabolite produced by certain Penicillium species, while zearalenone is an estrogenic Fusarium mycotoxin; elevation of these two with most other measured mycotoxins normal suggests selective exposure rather than a broad multi-mycotoxin pattern.

laying out figure…
2 of 6 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim links mycophenolic acid to Penicillium and zearalenone to Fusarium, and notes that zearalenone has estrogenic activity. It also frames the urine pattern as potentially selective, while acknowledging that spot urine results are limited by timing, metabolism, dilution, and related measurement factors. The pattern cannot identify the exposure source or rule out broader intermittent exposure.

Verified conclusion

The fungal identities and biological activity in the claim are well established; the inference drawn from a two-analyte urinary pattern is substantially more limited.

Established fungal and estrogenic biology

  • Mycophenolic acid (MPA) is a secondary metabolite produced by certain Penicillium species, notably P. brevicompactum and P. roqueforti. In P. brevicompactum, deletion of the cluster polyketide-synthase gene mpaC abolishes MPA production, providing direct functional evidence. This should not be generalized to all Penicillium.
  • Zearalenone is a Fusarium mycotoxin, including from F. graminearum and F. culmorum. Its biosynthesis involves polyketide-pathway genes including PKS4, PKS13, ZEB1, and ZEB2.
  • Zearalenone is estrogenically active: it competitively engages ERα and ERβ and activates estrogen-responsive transcription. In one assay at 1 μM, it reached ~91% of maximal ERα and 27% of ERβ response, although estimated in-vivo potency is only ~0.1–1% of estradiol and depends on experimental context.

Interpreting the urine pattern

  • Elevation of MPA and zearalenone with other tested analytes normal is compatible with a selective detectable-exposure pattern in that particular urine sample, but does not establish selective exposure or exclude broader intermittent exposure.
  • A spot urine result reflects recent intake and is affected by sampling time, dilution, metabolism, conjugation, and assay matrix effects. Zearalenone is metabolized to α- and β-zearalenol, with most metabolites excreted as glucuronides; interpretation is strongest when these are considered.
  • Urinary mycotoxin testing cannot determine whether exposure was dietary versus inhalational, identify a source, or establish toxicity or mold-related illness.

Bottom line

  • The statements about MPA and zearalenone are strongly supported. The “selective rather than broad exposure” interpretation is a low-confidence hypothesis, not a diagnostic conclusion.

References

  1. Molecular Basis for Mycophenolic Acid Biosynthesis in Penicillium brevicompactum — journals.asm.org ↗
  2. Secondary Metabolites Produced by the Blue-Cheese Ripening Mold Penicillium roqueforti; Biosynthesis and Regulation Mechanisms — ncbi.nlm.nih.gov ↗
  3. Screening and identification of a Penicillium brevicompactum strain isolated from the fruiting body of Inonotus obliquus and the fermentation production of mycophenolic acid - Annals of Microbiology — annalsmicrobiology.biomedcentral.com ↗
  4. SECONDARY METABOLITES FROM MARINE PENICILLIUM BREVICOMPACTUM — scielo.cl ↗
  5. Zearalenone, an Estrogenic Mycotoxin, Is an Immunotoxic Compound — pmc.ncbi.nlm.nih.gov ↗
  6. Zearalenone and the Immune Response — mdpi.com ↗
  7. 978. Zearalenone (WHO Food Additives Series 44) - Inchem.org — inchem.org ↗
  8. OPINION OF THE SCIENTIFIC COMMITTEE ON FOOD — ec.europa.eu ↗
  9. Use of Unvalidated Urine Mycotoxin Tests for the Clinical ... — cdc.gov ↗
  10. ACMT Position Statement - American College of Medical Toxicology — acmt.net ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible12 sourcesDo some metals, fungal toxins, and reactive chemicals increase hepatic conjugation and glutathione use while urine markers mainly reflect exposure?→Plausible11 sourcesCan gadolinium remain in the body after contrast MRI despite normal kidneys?→